BUSULFEX

This brand name is authorized in Hong Kong, Israel, Japan, Singapore, United States

Active ingredients

The drug BUSULFEX contains one active pharmaceutical ingredient (API):

1 Busulfan UNII G1LN9045DK - BUSULFAN

Busulfan is a potent cytotoxic agent and a bifunctional alkylating agent. In aqueous media, release of the methanesulphonate groups produces carbonium ions which can alkylate DNA, thought to be an important biological mechanism for its cytotoxic effect. Read about Busulfan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BUSULFEX Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AB01	Busulfan	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AB Alkyl sulfonates
Discover more medicines within L01AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 50627
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6995
Country: JP	医薬品医療機器総合機構	Identifier(s): 4213400A2025
Country: SG	Health Sciences Authority	Identifier(s): 13260P
Country: US	FDA, National Drug Code	Identifier(s): 59148-047, 59148-070